Recruiting

A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(24 sites)

China

Anhui Provincial Hospital, Hefei, Anhui

The Second People's Hospital of Hefei, Hefei, Anhui

Peking Union Medical College Hospital, Beijing, Beijing Municipality

Chongqing Traditional Chinese Medicine Hospital, Chongqing, Chongqing Municipality

The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality

Guangdong Provincial People's Hospital, Guangzhou, Guangdong

Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong

Shenzhen Second People's Hospital, Shenzhen, Guangdong

The First Affiliated Hospital of Henan University, Kaifeng, Henan

RenMin Hospital Of Wuhan University, Wuhan, Hubei

Huai'an First People's Hospital, Huai'an, Jiangsu

The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu

The Fourth Affiliated Hospital of Soochow University, Suzhou, Jiangsu

Xuzhou Medical University Affiliated Hospital, Xuzhou, Jiangsu

Qilu Hospital of Shandong University, Qingdao, Shandong

Zibo Municipal Hospital, Zibo, Shandong

Rui Jin Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality

Shanghai Fudan University HuaShan Hospital, Shanghai, Shanghai Municipality

Yangzhi Affiliated Rehabilitation Hospital of Tongji University, Shanghai, Shanghai Municipality

Shanxi Bethune Hospital, Taiyuan, Shanxi

Shanxi provincial people's Hospital, Taiyuan, Shanxi

West China Hospital，Sichuan University, Chengdu, Sichuan

Tianjin Medical University General Hospital, Tianjin, Tianjin Municipality

The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan